BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21749905)

  • 1. Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified 'optimal' multi-feature paradigm.
    Fisher DJ; Grant B; Smith DM; Borracci G; Labelle A; Knott VJ
    Int J Psychophysiol; 2011 Sep; 81(3):245-51. PubMed ID: 21749905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Labelle A; Knott VJ
    Schizophr Res; 2012 Aug; 139(1-3):237-45. PubMed ID: 22727705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.
    Fisher DJ; Grant B; Smith DM; Borracci G; Labelle A; Knott VJ
    Psychiatry Res; 2012 Apr; 196(2-3):181-7. PubMed ID: 22425471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The right profile: mismatch negativity in schizophrenia with and without auditory hallucinations as measured by a multi-feature paradigm.
    Fisher DJ; Labelle A; Knott VJ
    Clin Neurophysiol; 2008 Apr; 119(4):909-21. PubMed ID: 18261954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Smith DM; Labelle A; Knott VJ
    Biol Psychol; 2014 Jul; 100():43-9. PubMed ID: 24865523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory hallucinations and the mismatch negativity: processing speech and non-speech sounds in schizophrenia.
    Fisher DJ; Labelle A; Knott VJ
    Int J Psychophysiol; 2008 Oct; 70(1):3-15. PubMed ID: 18511139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of deviant probability on the 'optimal' multi-feature mismatch negativity (MMN) paradigm.
    Fisher DJ; Grant B; Smith DM; Knott VJ
    Int J Psychophysiol; 2011 Feb; 79(2):311-5. PubMed ID: 21111009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia.
    Todd J; Michie PT; Schall U; Karayanidis F; Yabe H; Näätänen R
    Biol Psychiatry; 2008 Jan; 63(1):58-64. PubMed ID: 17585889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of extensive auditory discrimination profiles using the mismatch negativity (MMN) of the auditory event-related potential (ERP).
    Pakarinen S; Takegata R; Rinne T; Huotilainen M; Näätänen R
    Clin Neurophysiol; 2007 Jan; 118(1):177-85. PubMed ID: 17070103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory discrimination profiles of speech sound changes in 6-year-old children as determined with the multi-feature MMN paradigm.
    Lovio R; Pakarinen S; Huotilainen M; Alku P; Silvennoinen S; Näätänen R; Kujala T
    Clin Neurophysiol; 2009 May; 120(5):916-21. PubMed ID: 19386542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized mismatch negativity paradigm reflects deficits in schizophrenia patients. A combined EEG and MEG study.
    Thönnessen H; Zvyagintsev M; Harke KC; Boers F; Dammers J; Norra Ch; Mathiak K
    Biol Psychol; 2008 Feb; 77(2):205-16. PubMed ID: 18060677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal auditory pattern perception in schizophrenia.
    Haigh SM; Coffman BA; Murphy TK; Butera CD; Salisbury DF
    Schizophr Res; 2016 Oct; 176(2-3):473-479. PubMed ID: 27502427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical detection and analysis of mismatch negativity derived by a multi-deviant design from normal hearing children.
    Petermann M; Kummer P; Burger M; Lohscheller J; Eysholdt U; Döllinger M
    Hear Res; 2009 Jan; 247(2):128-36. PubMed ID: 19071204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
    Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
    Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia.
    Lee M; Sehatpour P; Dias EC; Silipo GS; Kantrowitz JT; Martinez AM; Javitt DC
    Schizophr Res; 2018 Jan; 191():10-17. PubMed ID: 28779851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pavlovian conditioning-induced hallucinations reduce MMN amplitudes for duration but not frequency deviants.
    Abalo-Rodríguez I; Santos-Mayo A; Moratti S
    Schizophr Res; 2023 Jun; 256():63-71. PubMed ID: 37156071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast multi-feature paradigm for recording several mismatch negativities (MMNs) to phonetic and acoustic changes in speech sounds.
    Pakarinen S; Lovio R; Huotilainen M; Alku P; Näätänen R; Kujala T
    Biol Psychol; 2009 Dec; 82(3):219-26. PubMed ID: 19646504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch negativity is a stronger indicator of functional outcomes than neurocognition or theory of mind in patients with schizophrenia.
    Lee SH; Sung K; Lee KS; Moon E; Kim CG
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():213-9. PubMed ID: 24161665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.